Leading Oregon Compliance Company Gets Ready for Psilocybin
PORTLAND – Hemp, CBD, THC-cannabis and now psilocybin compliance? Bring it on say compliance consulting firm Allay. They announced this week they’re launching a new division focused on supporting businesses with the regulation of the newly legalized therapeutic psilocybin market in Oregon and any states that follow.
Allay, founded by one of the nation’s first designated cannabis regulators, assists stakeholders in highly regulated industries across all operations to obtain licensure and ensure long-term compliance at the federal, state and local levels.
“We’re passionate about plant medicine and are well positioned to help companies produce safe plant-based products,” said Kim Stuck, CEO and Founder of Allay. “Even if psilocybin sales are a couple of years away, as the cannabis and hemp industries have taught us, having regulatory compliance baked into the business model’s DNA is a key differentiator for long-term success and scalable growth.”
Allay, which serves clients nationwide and internationally, offers a comprehensive approach to product and food safety, OSHA and fire compliance, cGMP and ISO certifications. The firm is adding a Good Agricultural Practices (GAP) specialization to the psilocybin division, expanding its consumable products safety knowledge and offerings.
“We’re accustomed to working in emerging industries and understand the challenge in preparing for regulations that have yet to be created,” said Ms. Stuck.
As of January 2021, Ms. Stuck has applied to help craft Oregon’s historic new psychedelic mushrooms regulations.
Reunion Neuroscience to be Acquired by MPM BioImpact in $13.1 Million All-Cash Deal
LOS ANGELES-- Reunion Neuroscience Inc. a clinical-stage biopharmaceutical company specializing in innovative therapies for underserved mental health conditions, has announced a definitive arrangement agreement with MPM BioImpact, a leading biotechnology investment firm. Under the agreement, ...
California’s Regulated Cannabis Market Sees Decline in Sales and Tax Revenue in Q1 2023
LOS ANGELES-- California's hopes of increased consumer participation in the regulated cannabis market did not translate into a boost in licensed retail sales or state tax revenue during the first quarter of 2023. According to ...
C21 Investments Repays $30 Million Debt to CEO Sonny Newman
LOS ANGELES-- C21 Investments Inc., a vertically integrated cannabis company, announced today the successful completion of the full repayment of its $30 million senior secured note owed to Sonny Newman, the Company's President and Chief ...